Skip to content Skip to content

Press Releases


Filter Releases
 
INCLINE VILLAGE, Nev., Oct. 28, 2015 /PRNewswire/ -- PDL BioPharma, Inc. (PDL, or the Company) (NASDAQ: PDLI) today announced that the Company will release its third quarter 2015 financial results for the period ended September 30, 2015, on Wednesday, November 4, 2015, after market close. PDL's management will host a conference call and webcast tha...
INCLINE VILLAGE, Nev., Sept. 23, 2015 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that PDL has received approximately $21.4 million in connection with the termination of PDL's structured financing agreement with Avinger, Inc. (NASDAQ: AVGR), which included repayment of the full principal amount outstanding of $20.6 mill...
INCLINE VILLAGE, Nev., Sept. 21, 2015 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL") (Nasdaq: PDLI) announced today that it has acquired a portion of the royalties on expected sales of AcelRx Pharmaceuticals Inc.'s ("AcelRx") (Nasdaq: ACRX) Zalviso™ (sufentanil sublingual tablet system) in the European Union, Switzerland and Australia by its com...
INCLINE VILLAGE, Nev., Sept. 16, 2015 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL") (NASDAQ: PDLI) today announced that Samuel R. Saks, M.D. has been appointed to the company's board of directors. Dr. Saks serves as a board member for several biotechnology and pharmaceutical companies. Dr. Saks brings over 35 years of biotechnology management ...
INCLINE VILLAGE, Nev., Sept. 14, 2015 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that it has paid the September 11, 2015, regular quarterly dividend payment of $0.15 per share to all stockholders owning shares of PDL as of September 4, 2015, the record date. About PDL BioPharma PDL manages a portfolio of patent...
INCLINE VILLAGE, Nev., Sept. 10, 2015 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that John P. McLaughlin, the company's president and chief executive officer, will present at the 6th Annual Credit Suisse US Small & Mid Cap Conference in New York City next week. The group presentation will occur on Thursday, September 1...
INCLINE VILLAGE, Nev., Sept. 8, 2015 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL") (NASDAQ: PDLI) today announced that Paul R. Edick has been appointed to the company's board of directors. Mr. Edick is currently managing partner of 3G Advisors, LLC, a consultancy to the pharmaceutical, healthcare and healthcare investor communities. Mr. Edick ...
INCLINE VILLAGE, Nev., Aug. 5, 2015 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today reported financial results for the second quarter and six months ended June 30, 2015. Total revenues were $138.1 million for the three months ended June 30, 2015, compared to $162.8 million for the same period of 2014, and $287.8 million for t...
INCLINE VILLAGE, Nev., July 29, 2015 /PRNewswire/ -- PDL BioPharma, Inc. (NASDAQ: PDLI) today announced that it has entered into a revenue interest assignment agreement (the "Agreement") in which it has agreed to provide ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) with up to $200 million in revenue interest financing in exchange for royalties on the...
INCLINE VILLAGE, Nev., July 28, 2015 /PRNewswire/ -- PDL BioPharma, Inc. (PDL, or the Company) (NASDAQ: PDLI) today announced that the Company will release its second quarter 2015 financial results for the period ended June 30, 2015, on Wednesday, August 5, 2015, after market close. PDL's management will host a conference call and webcast that day ...
INCLINE VILLAGE, Nev., June 29, 2015 /PRNewswire/ -- PDL BioPharma, Inc. (NASDAQ: PDLI) today announced that it has entered into a credit agreement with CareView Communications, Inc. (OTCQB: CRVW) whereby PDL will provide CareView with up to $40 million of secured debt financing. CareView is an information technology provider to the healthcare indu...
INCLINE VILLAGE, Nev., June 25, 2015 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that John P. McLaughlin, the company's president and chief executive officer, will present at the Nasdaq 32nd Investor Program in London, England.  The fireside chat-style of presentation will be webcast and will occur on Tuesday, June 30, ...
INCLINE VILLAGE, Nev., June 24, 2015 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the company has appointed Steffen Pietzke, CPA, to the position of controller and chief accounting officer. Mr. Pietzke officially joins the company this week. "Steffen is an excellent addition to PDL and brings over 14 years of...
INCLINE VILLAGE, Nev., June 15, 2015 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that it has paid the June 12, 2015, regular quarterly dividend payment of $0.15 per share to all stockholders owning shares of PDL as of June 5, 2015, the record date. About PDL BioPharmaPDL manages a portfolio of patents and royalt...
INCLINE VILLAGE, Nev., May 27, 2015 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that John P. McLaughlin, the company's president and chief executive officer, will present at the Jefferies 2015 Global Healthcare Conference next week in New York City.  The presentation, which will be webcast, will occur on Wednesday, June...
Page: First Previous
...
...
Next Last
 
= add release to Briefcase